Charles Brenner, PhD, director of the Obesity Initiative at the University of Iowa, discusses properties of nicotinamide riboside that have been uncovered since its initial discovery in 2004.
In this video, Scott Kahan, MD, MPH, director of the National Center for Weight and Wellness in Washington, DC, discusses the 5 "A's" of obesity counseling.
In this video, Diane Mould, PhD, from Projections Research, discusses the important role of monoclonal antibodies in the management of inflammatory diseases.
